PAPER Hu L, Côté SL, Cuello AC

Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.

Exp Neurol. 1997 Jan;143(1):162-71. PubMed.

PAPER Finch CE, Cohen DM

Aging, metabolism, and Alzheimer disease: review and hypotheses.

Exp Neurol. 1997 Jan;143(1):82-102. PubMed.

PAPER Weber LL, Leissring MA, Yang AJ, Glabe CG, Cribbs DH, Laferla FM

Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques.

Exp Neurol. 1997 Jan;143(1):37-44. PubMed.

PAPER Hellström A, Almkvist O

Tone duration discrimination in demented, memory-impaired, and healthy elderly.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):49-54. PubMed.

PAPER Strittmatter M, Hamann GF, Grauer MT, Cramer H, Schimrigk K

Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):34-42. PubMed.

PAPER Augustinsson LE, Blennow K, Blomstrand C, Bråne G, Ekman R, Fredman P, Karlsson I, Kihlgren M, Lehmann W, Lekman A, Månsson JE, Ramström I, Wallin A, Wikkelsö C, Gottfries CG, Svennerholm L

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):26-33. PubMed.

PAPER Politoff AL, Monson N

Age vs. aging in the pathogenesis of senile dementia of the Alzheimer type: electrophysiological evidence.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):18-25. PubMed.

PAPER Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC

Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.

Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):1-8. PubMed.

PAPER Knight JA

Reactive oxygen species and the neurodegenerative disorders.

Ann Clin Lab Sci. 1997 Jan-Feb;27(1):11-25. PubMed.

PAPER Messmer-Joudrier S, Sagot Y, Mattenberger L, James RW, Kato AC

Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells.

Eur J Neurosci. 1996 Dec;8(12):2652-61. PubMed.

PAPER Dartigues JF, Commenges D, Letenneur D, Barberger-Gateau P, Gilleron V, Fabrigoule C, Mazaux JM, Orgogozo JM, Salamon R

Cognitive predictors of dementia in elderly community residents.

Neuroepidemiology. 1997;16(1):29-39. PubMed.

PAPER Matsumoto A, Enomoto T, Fujiwara Y, Baba H, Matsumoto R

Enhanced aggregation of beta-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa serine protease prepared from human brain.

Neurosci Lett. 1996 Dec 20;220(3):159-62. PubMed.

PAPER Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

J Neurosci. 1997 Feb 1;17(3):1046-54. PubMed.

PAPER Yamazaki T, Koo EH, Selkoe DJ

Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells.

J Neurosci. 1997 Feb 1;17(3):1004-10. PubMed.

PAPER Mok SS, Evin G, Li QX, Smith AI, Beyreuther K, Masters CL, Small DH

A novel metalloprotease in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments.

Biochemistry. 1997 Jan 7;36(1):156-63. PubMed.